Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison
Open Access
- 28 June 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (25) , 3435-3442
- https://doi.org/10.1161/circulationaha.104.513952
Abstract
Background— Published rates of coronary restenosis have fallen below 10% in drug-eluting stent trials. Early evaluations of new stents have used continuous end points that are presumed surrogates for restenosis, but the generalizability and power of such end points have not been examined systematically.Keywords
This publication has 27 references indexed in Scilit:
- Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting StentsCirculation, 2005
- Six- and Twelve-Month Results From First Human Experience Using Everolimus-Eluting Stents With Bioabsorbable PolymerCirculation, 2004
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- TAXUS ICirculation, 2003
- Stenting in small coronary arteries (SISCA) trial: A randomized comparison between balloon angioplasty and the heparin-coated beStentJournal of the American College of Cardiology, 2001
- Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteriesPublished by Oxford University Press (OUP) ,2000
- Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomyJournal of the American College of Cardiology, 1993
- Novel approach to the analysis of restenosis after the use of three new coronary devicesJournal of the American College of Cardiology, 1992